Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9744164 | 0.82 | TDP1 (0.39) | CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL4170188 | 0.78 | TRPA1 (0.36) | TRPA1ALDH1A1TSHRCYP1A1CYP1A2 | |
| SCHEMBL535892 | 0.78 | GABRA1 (0.45) | ALDH1A1GABRA1GABRB2 | |
| SCHEMBL3644028 | 0.76 | PNMT (0.44) | GABRA1GABRB2 | |
| SCHEMBL29513232 | 0.76 | CYP19A1 (0.46) | ALDH1A1TSHRCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL899 | 0.76 | CYP19A1 (0.46) | ALDH1A1TSHRCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL1379506 | 0.76 | ALDH1A1 (0.42) | ALDH1A1TSHRGABRA1GABRB2 | |
| SCHEMBL873220 | 0.76 | FFAR1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL9317847 | 0.76 | FFAR1 (0.31) | ALDH1A1GABRA1GABRB2 | |
| SCHEMBL1465518 | 0.76 | GABRA1 (0.30) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5098996-A | Fluorination of compounds for use in diagnosis of nuclear medicine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-03-24 | — | — | US | claimed |
| CN-104007629-B | Liquid developer, image forming apparatus and method, developer box and handle box | 富士施乐株式会社 | 2019-11-29 | — | — | CN | disclosed |
| CN-106019868-B | Electrophtography photosensor | 柯尼卡美能达株式会社 | 2019-11-08 | — | — | CN | disclosed |
| CN-105527807-B | Toner for developing electrostatic latent image | 柯尼卡美能达株式会社 | 2019-11-05 | — | — | CN | disclosed |
| CN-105527805-B | Electrostatic image developing toner | Koyanagi Miyoshi (JP) | 2019-11-01 | — | — | CN | disclosed |
| CN-110297404-A | Toner, developer, toner cartridge, process cartridge, image forming apparatus and image forming method | 富士施乐株式会社 | 2019-10-01 | — | — | CN | disclosed |
| CN-110083024-A | Toner | 佳能株式会社 | 2019-08-02 | — | — | CN | disclosed |
| CN-109426103-A | Developing toner for electrostatic latent images and two-component developing agent | 柯尼卡美能达株式会社 | 2019-03-05 | — | — | CN | disclosed |
| CN-104423186-B | Developing toner for electrostatic latent images | 柯尼卡美能达株式会社 | 2018-12-21 | — | — | CN | disclosed |
| CN-108873633-A | Toner | 佳能株式会社 | 2018-11-23 | — | — | CN | disclosed |
| CN-1062711-C | Pesticide and fungicide of unsaturated oximido ethers | SHENYANG CHEMICAL INST MINISTR (CN) | 2001-03-07 | — | — | CN | disclosed |
| CN-1191670-A | Pesticide and fungicide of unsaturated oximido ethers | SHENYANG CHEMICAL INST MINISTR (CN) | 1998-09-02 | — | — | CN | disclosed |
| US-5753652-A | Antiretroviral hydrazine derivatives | NOVARTIS CORPORATION (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0594540-B1 | Antiretroviral acyl compounds | CIBA GEIGY AG (CH) | 1998-04-01 | — | — | EP | disclosed |
| EP-0604368-B1 | Anti retroviral hydrazine derivatives | CIBA GEIGY AG (CH) | 1996-09-18 | — | — | EP | disclosed |
| US-5430139-A | Viricides; effective against herpes and cytomegalo viruses | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1995-07-04 | — | — | US | disclosed |
| EP-0604368-A1 | Anti retroviral hydrazine derivatives | CIBA-GEIGY AG (CH) | 1994-06-29 | — | — | EP | disclosed |
| EP-0594540-A1 | Antiretroviral acyl compounds | CIBA-GEIGY AG (CH) | 1994-04-27 | — | — | EP | disclosed |
| US-5098996-A | Fluorination of compounds for use in diagnosis of nuclear medicine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-03-24 | — | — | US | disclosed |
| US-5098996-A | Fluorination of compounds for use in diagnosis of nuclear medicine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-03-24 | — | — | US | disclosed |